HSIC

SEC source: 0001209191-19-017451 · doc4.xml · nonDerivative · entry 1

Siegel Walter · CIK 0001342060 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,606

SEC source: 0001209191-19-017443 · doc4.xml · nonDerivative · entry 2

PALADINO STEVEN · CIK 0001194353 · Director · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,729

F1 · shares: Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 4, 2016 grant of performance-based restricted stock/units.

SEC source: 0001209191-19-017443 · doc4.xml · nonDerivative · entry 1

PALADINO STEVEN · CIK 0001194353 · Director · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,299

SEC source: 0001209191-19-017441 · doc4.xml · nonDerivative · entry 2

MLOTEK MARK E · CIK 0001194352 · Director · EVP, Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,744

F1 · shares: Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 4, 2016 grant of performance-based restricted stock/units.

SEC source: 0001209191-19-017441 · doc4.xml · nonDerivative · entry 1

MLOTEK MARK E · CIK 0001194352 · Director · EVP, Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,401

SEC source: 0001209191-19-017439 · doc4.xml · nonDerivative · entry 1

LASKAWY PHILIP A · CIK 0001099296 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,011

F1 · price: The price reflects a weighted average of sales made at prices ranging from $59.122 to $59.125 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-017432 · doc4.xml · nonDerivative · entry 2

Ettinger Michael S · CIK 0001577158 · SVP Corp/Legal Ch of Staff Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,718

F1 · shares: Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 4, 2016 grant of performance-based restricted stock/units.

SEC source: 0001209191-19-017432 · doc4.xml · nonDerivative · entry 1

Ettinger Michael S · CIK 0001577158 · SVP Corp/Legal Ch of Staff Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,404

SEC source: 0001209191-19-017425 · doc4.xml · nonDerivative · entry 2

BRESLAWSKI JAMES P · CIK 0001194347 · Director · Vice Chairman, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,822

F1 · shares: Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 4, 2016 grant of performance-based restricted stock/units.

SEC source: 0001209191-19-017425 · doc4.xml · nonDerivative · entry 1

BRESLAWSKI JAMES P · CIK 0001194347 · Director · Vice Chairman, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,732

SEC source: 0001209191-19-017422 · doc4.xml · nonDerivative · entry 4

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,145

F4 · shares: Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 4, 2016 grant of performance-based restricted stock/units.

SEC source: 0001209191-19-017422 · doc4.xml · nonDerivative · entry 3

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,874

SEC source: 0001209191-19-017421 · doc4.xml · nonDerivative · entry 2

BENJAMIN GERALD A · CIK 0001194346 · Director · EVP, Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,246

F1 · shares: Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 4, 2016 grant of performance-based restricted stock/units.

SEC source: 0001209191-19-017421 · doc4.xml · nonDerivative · entry 1

BENJAMIN GERALD A · CIK 0001194346 · Director · EVP, Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,816

SEC source: 0001209191-19-016575 · doc4.xml · nonDerivative · entry 1

Siegel Walter · CIK 0001342060 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,010

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2015 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016564 · doc4.xml · nonDerivative · entry 1

SHEARES BRADLEY T · CIK 0001181183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,326

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 2, 2018 grant of time-based restricted stock/units. (Actual vesting date of March 2, 2018 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016532 · doc4.xml · nonDerivative · entry 1

Raphael Carol · CIK 0001333282 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,705

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 2, 2018 grant of time-based restricted stock/units. (Actual vesting date of March 2, 2018 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016548 · doc4.xml · nonDerivative · entry 1

Rekow E Dianne · CIK 0001609814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,809

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 2, 2018 grant of time-based restricted stock/units. (Actual vesting date of March 2, 2018 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016524 · doc4.xml · nonDerivative · entry 1

PALADINO STEVEN · CIK 0001194353 · Director · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,514

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2015 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016518 · doc4.xml · nonDerivative · entry 1

MLOTEK MARK E · CIK 0001194352 · Director · EVP, Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,135

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2015 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016503 · doc4.xml · nonDerivative · entry 1

Ettinger Michael S · CIK 0001577158 · SVP Corp/Legal Ch of Staff Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,214

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2015 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016494 · doc4.xml · nonDerivative · entry 2

Brons Paul · CIK 0001323692 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,368

F3 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the distribution of the reporting person's March 3, 2015 grant of time-based restricted stock/units, which vested on March 3, 2016 but, per the reporting person's election, was deferred until March 3, 2019. (March 3, 2019 was a non-business day, so distribution of the shares was made on the preceding business day.)

SEC source: 0001209191-19-016494 · doc4.xml · nonDerivative · entry 1

Brons Paul · CIK 0001323692 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,686

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 2, 2018 grant of time-based restricted stock/units. (Actual vesting date of March 2, 2018 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016484 · doc4.xml · nonDerivative · entry 1

BRESLAWSKI JAMES P · CIK 0001194347 · Director · Vice Chairman, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,428

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2015 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016465 · doc4.xml · nonDerivative · entry 2

ALPERIN BARRY J · CIK 0001194358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,307

F3 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the distribution of the reporting person's March 3, 2015 grant of time-based restricted stock/units, which vested on March 3, 2016 but, per the reporting person's election, was deferred until March 3, 2019. (March 3, 2019 was a non-business day, so distribution of the shares was made on the preceding business day.)

SEC source: 0001209191-19-016465 · doc4.xml · nonDerivative · entry 1

ALPERIN BARRY J · CIK 0001194358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,038

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 2, 2018 grant of time-based restricted stock/units. (Actual vesting date of March 2, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-016474 · doc4.xml · nonDerivative · entry 1

BENJAMIN GERALD A · CIK 0001194346 · Director · EVP, Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,031

F1 · shares: Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2015 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2019 was a non-business day so vesting occurred on the preceding business day.)

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-017422 · doc4.xml · nonDerivative · entry 2

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 875,803

F1 · price: Gift, not applicable.

F3 · ownership.nature: Represents (i) 460,899 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary; (ii) 34 shares held by Mrs. Bergman and (iii) 414,870 shares held by the 2010 Bergman Family #2, LLC of which Marion Bergman, Stanley M. Bergman's wife, is a manager. The amounts in the previous sentence reflect a transfer by the Bergman Family 2010 Trust 2 of 414,870 shares of Issuer Common Stock to the Bergman Family 2010 Trust #2, LLC on February 27, 2019.

SEC source: 0001209191-19-017422 · doc4.xml · nonDerivative · entry 1

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,777

F1 · price: Gift, not applicable.

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table 1 was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-19-013682 · doc4.xml · nonDerivative · entry 1

Margulies Anne H. · CIK 0001743156 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,246

F1 · price: The price reflects a weighted average of purchases made at prices ranging from $60.59 to $60.60 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares purchased at each separate price for this transaction.

F2 · balance_after: The number of restricted stock/units included in Column 5 of Table I was adjusted in connection with the spin-off and subsequent merger of the Issuer's animal health business on February 7, 2019 (the "Spin-Off"). The adjustment reflects the product of (i) the number of restricted stock/unit awards immediately prior to the Spin-Off and (ii) a ratio equal to a fraction, with the numerator equal to the average of the high and low pre-Spin-Off trading prices of the Issuer's common stock on February 6, 2019 (the "Issuer Pre-Spin-Off Price") and the denominator equal to the difference between (A) the Issuer Pre-Spin-Off Price and (B) the product of (x) 0.4 and (y) the average of the high and low trading prices of the common stock of Covetrus, Inc. (the combined company resulting from the Spin-Off) on February 8, 2019, the trading day immediately following the distribution date of the Spin-Off.

SEC source: 0001209191-18-064398 · doc4.xml · derivative · entry 2

Margulies Anne H. · CIK 0001743156 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593

Underlying: Common Stock, par value $0.01 per share · 263 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock.

F2 · shares: Represents the number of shares of phantom stock credited to the reporting person's phantom stock account pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), representing an exempt transaction under the Plan. The number of shares of phantom stock credited to the reporting person's phantom stock account is determined by dividing the amount of deferred eligible director fees by the closing price of a share of Issuer common stock on the award date.

F3 · derivative.exercise_date: The balance in the reporting person's phantom share account is distributed to the reporting person in Issuer common stock following the termination of the reporting person's directorship, the reporting person's death or disability or a change of control of the Issuer.

F3 · derivative.expiration_date: The balance in the reporting person's phantom share account is distributed to the reporting person in Issuer common stock following the termination of the reporting person's directorship, the reporting person's death or disability or a change of control of the Issuer.

F4 · balance_after: Represents the aggregate number of shares of phantom stock allocated to the reporting person under the Plan as of the award date based on the closing price of a share of the Issuer's common stock on the award date.

SEC source: 0001209191-19-007724 · doc5.xml · nonDerivative · entry 1

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,438

F1 · price: Gift, not applicable.

SEC source: 0001209191-18-062224 · doc4.xml · nonDerivative · entry 3

Ettinger Michael S · CIK 0001577158 · SVP Corp/Legal Ch of Staff Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,673

F2 · price: The price reflects a weighted average of sales made at prices ranging from $84.300 to $84.495 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 18

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 877,703

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F19 · price: The price reflects a weighted average of sales made at prices ranging from $86.67 to $87.49 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F20 · ownership.nature: Represents (i) 877,669 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 17

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 882,645

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F17 · price: The price reflects a weighted average of sales made at prices ranging from $85.67 to $86.63 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F18 · ownership.nature: Represents (i) 882,611 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 16

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 891,035

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F15 · price: The price reflects a weighted average of sales made at prices ranging from $84.68 to $85.65 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F16 · ownership.nature: Represents (i) 891,001 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 15

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 912,203

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F13 · price: The price reflects a weighted average of sales made at prices ranging from $88.73 to $89.33 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F14 · ownership.nature: Represents (i) 912,169 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 14

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 913,503

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F11 · price: The price reflects a weighted average of sales made at prices ranging from $87.74 to $88.72 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F12 · ownership.nature: Represents (i) 913,469 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 13

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 921,271

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F9 · price: The price reflects a weighted average of sales made at prices ranging from $86.75 to $87.72 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F10 · ownership.nature: Represents (i) 921,237 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 12

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 929,456

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F7 · price: The price reflects a weighted average of sales made at prices ranging from $85.76 to $86.74 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F8 · ownership.nature: Represents (i) 929,422 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 11

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 942,291

F4 · shares: The sale of shares held by the Bergman Family 2010 Trust 2 is being reported because Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary of the trust. A third party is the other co-trustee. The sale was made as part of the trust's diversification plan.

F5 · price: The price reflects a weighted average of sales made at prices ranging from $84.75 to $85.73 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

F6 · ownership.nature: Represents (i) 942,257 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman.

SEC source: 0001209191-19-007730 · doc5.xml · nonDerivative · entry 1

MLOTEK MARK E · CIK 0001194352 · Director · EVP, Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,181

F1 · price: Gift, not applicable.

SEC source: 0001209191-18-060847 · doc4.xml · nonDerivative · entry 1

PALADINO STEVEN · CIK 0001194353 · Director · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,304

F1 · price: The price reflects a weighted average of sales made at prices ranging from $90.03 to $ 90.13 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

SEC source: 0001209191-18-062224 · doc4.xml · nonDerivative · entry 2

Ettinger Michael S · CIK 0001577158 · SVP Corp/Legal Ch of Staff Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,098

F1 · price: Gift, not applicable.

SEC source: 0001209191-18-060589 · doc4.xml · nonDerivative · entry 1

McKinley David · CIK 0001577440 · CCO&Pres. Corp. Com. Dev. Grp.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,012

F1 · price: The price reflects a weighted average of sales made at prices ranging from $88.580 to $88.955 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 10

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,243

F1 · price: Gift, not applicable.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 9

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,545

F1 · price: Gift, not applicable.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 8

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,883

F1 · price: Gift, not applicable.

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 7

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 946,703

F1 · price: Gift, not applicable.

F3 · ownership.nature: Represents (i) 946,669 shares held by the Bergman Family 2010 Trust 2, of which Marion Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary and (ii) 34 shares held by Mrs. Bergman. 1

SEC source: 0001209191-18-061643 · doc4.xml · nonDerivative · entry 6

BERGMAN STANLEY M · CIK 0001008413 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,906

F1 · price: Gift, not applicable.